• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期结肠癌监测:复发模式与时间以及5年监测的作用

Early-Stage Colon Cancer Surveillance: Pattern and Timing of Recurrence and the Role of 5-Year Surveillance.

作者信息

Ferreira Pinto Paula, Peyroteo Mariana, Baía Catarina, Marques Mariana, Cardoso Maria João, Videira José Flávio, Abreu de Sousa Joaquim

机构信息

Surgical Oncology Department, Instituto Português de Oncologia do Porto, Porto, Portugal.

出版信息

GE Port J Gastroenterol. 2024 Aug 16;32(2):109-117. doi: 10.1159/000540338. eCollection 2025 Apr.

DOI:10.1159/000540338
PMID:40171093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11961085/
Abstract

INTRODUCTION

Colorectal cancer is the third most prevalent cancer among both men and women with 80% of patients having localized disease enabling curative treatments. Given the low recurrence rate in early-stage disease, there is a growing interest in reviewing follow-up protocols. The aim of this study was to assess the frequency and timing of recurrence in early-stage colon cancer, as well as recurrence patterns.

METHODS

The data from all patients with colon adenocarcinoma consecutively treated with surgery at the Instituto Português de Oncologia do Porto, EPE, between January 2013 and December 2016, were retrospectively reviewed.

RESULTS

A total of 1,372 patients with colon cancer were submitted to surgery during the study period. From this group, 51.4% ( = 705) were early-stage colon cancers. Regarding the pathological stage, 3.5% were stage 0, 37.4% were stage I and 59.1% were stage II. The overall recurrence rate was 6.7%. When considering the group of patients without risk factors, the recurrence rate was 5.6%. The majority of recurrences occurred in the first 3 years of follow-up. The recurrence was diagnosed in the majority of patients through carcinoembryonic antigen elevation, followed by imaging exams. The presence of one or more risk factors (high nuclear grade, vascular invasion, extramural venous invasion, and perineural invasion) showed a statistically significant association with recurrence rate.

CONCLUSION

The recurrence rate was low in early-stage colon cancer, with the majority of recurrences occurring in the first 3 years. Our study results show that surveillance should be tailored according to individual risk factors.

摘要

引言

结直肠癌是男性和女性中第三大常见癌症,80%的患者患有局限性疾病,可行根治性治疗。鉴于早期疾病的复发率较低,人们对审查随访方案的兴趣与日俱增。本研究的目的是评估早期结肠癌复发的频率和时间,以及复发模式。

方法

回顾性分析了2013年1月至2016年12月期间在葡萄牙波尔图肿瘤研究所连续接受手术治疗的所有结肠腺癌患者的数据。

结果

在研究期间,共有1372例结肠癌患者接受了手术。其中,51.4%(n = 705)为早期结肠癌。在病理分期方面,0期占3.5%,I期占37.4%,II期占59.1%。总体复发率为6.7%。在无危险因素的患者组中,复发率为5.6%。大多数复发发生在随访的前3年。大多数患者通过癌胚抗原升高诊断复发,其次是影像学检查。存在一个或多个危险因素(高核分级、血管侵犯、壁外静脉侵犯和神经周围侵犯)与复发率具有统计学意义的关联。

结论

早期结肠癌的复发率较低,大多数复发发生在头3年。我们的研究结果表明,应根据个体危险因素进行监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0146/11961085/ef71bc0d88ef/pjg-2025-0032-0002-540338_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0146/11961085/941e33477529/pjg-2025-0032-0002-540338_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0146/11961085/e4b6597b4ba0/pjg-2025-0032-0002-540338_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0146/11961085/ef71bc0d88ef/pjg-2025-0032-0002-540338_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0146/11961085/941e33477529/pjg-2025-0032-0002-540338_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0146/11961085/e4b6597b4ba0/pjg-2025-0032-0002-540338_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0146/11961085/ef71bc0d88ef/pjg-2025-0032-0002-540338_F03.jpg

相似文献

1
Early-Stage Colon Cancer Surveillance: Pattern and Timing of Recurrence and the Role of 5-Year Surveillance.早期结肠癌监测:复发模式与时间以及5年监测的作用
GE Port J Gastroenterol. 2024 Aug 16;32(2):109-117. doi: 10.1159/000540338. eCollection 2025 Apr.
2
Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer.左半结肠癌是 II 期结肠癌术后复发的一个新的高危因素。
World J Surg Oncol. 2020 Mar 11;18(1):54. doi: 10.1186/s12957-020-01818-7.
3
Is Colonoscopy Alone Adequate for Surveillance in Stage I Colorectal Cancer?单纯结肠镜检查对I期结直肠癌进行监测是否足够?
Cancer Res Treat. 2025 Apr;57(2):507-518. doi: 10.4143/crt.2024.526. Epub 2024 Oct 4.
4
Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.UICC Ⅰ-Ⅲ期结直肠癌根治术后早期复发的预测因素。
J Surg Oncol. 2009 Dec 15;100(8):736-43. doi: 10.1002/jso.21404.
5
Prognostic Impact of Extramural Lymphatic, Vascular, and Perineural Invasion in Stage II Colon Cancer: A Comparison With Intramural Invasion.Ⅱ期结肠癌的黏膜下淋巴管、血管和神经浸润的预后影响:与黏膜内浸润的比较。
Dis Colon Rectum. 2023 Mar 1;66(3):366-373. doi: 10.1097/DCR.0000000000002339. Epub 2022 Mar 23.
6
Intensive Follow-Up After Curative Surgery for Colorectal Cancer.结直肠癌根治性手术后的强化随访
Acta Med Port. 2017 Sep 29;30(9):633-641. doi: 10.20344/amp.7889.
7
Development and Validation of a Prediction Model for Organ-Specific Recurrences After Curative Resection of Colon Cancer.开发和验证结肠癌根治术后器官特异性复发的预测模型。
Dis Colon Rectum. 2019 Sep;62(9):1043-1054. doi: 10.1097/DCR.0000000000001430.
8
Optimal Surveillance Protocols After Curative Resection in Patients With Stage IV Colorectal Cancer: A Multicenter Retrospective Study.IV期结直肠癌患者根治性切除术后的最佳监测方案:一项多中心回顾性研究
Dis Colon Rectum. 2018 Jan;61(1):51-57. doi: 10.1097/DCR.0000000000000950.
9
Predictors of Recurrence After Curative Surgery for Stage I Colon Cancer: Retrospective Cohort Analysis of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group.I期结肠癌根治性手术后复发的预测因素:意大利外科肿瘤学会结直肠癌网络协作组的回顾性队列分析
Ann Surg Open. 2024 Nov 18;5(4):e510. doi: 10.1097/AS9.0000000000000510. eCollection 2024 Dec.
10
Recurrence-Free Survival Outcomes Based on Novel Classification Combining Lymphovascular Invasion, Perineural Invasion, and T4 Status in Stage II-III Colon Cancer.基于将淋巴管侵犯、神经周围侵犯和T4状态相结合的新型分类的II-III期结肠癌无复发生存结果
Cancer Manag Res. 2022 Jun 20;14:2031-2040. doi: 10.2147/CMAR.S358939. eCollection 2022.

本文引用的文献

1
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
Risk Factors for the Diagnosis of Colorectal Cancer.结直肠癌诊断的危险因素。
Cancer Control. 2022 Jan-Dec;29:10732748211056692. doi: 10.1177/10732748211056692.
3
Should Colorectal Cancer Screening in Portugal Start at the Age of 45 Years? A Cost-Utility Analysis.葡萄牙的结直肠癌筛查应从45岁开始吗?一项成本效益分析。
GE Port J Gastroenterol. 2021 Sep;28(5):311-318. doi: 10.1159/000513592. Epub 2021 Feb 9.
4
Clinicopathological Features of Stage I-III Colorectal Cancer Recurrence Over 5 Years After Radical Surgery Without Receiving Neoadjuvant Therapy: Evidence From a Large Sample Study.根治性手术后未接受新辅助治疗的Ⅰ-Ⅲ期结直肠癌5年后复发的临床病理特征:一项大样本研究的证据
Front Surg. 2021 Aug 9;8:666400. doi: 10.3389/fsurg.2021.666400. eCollection 2021.
5
Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer.非转移性结肠癌的阶段依赖性复发模式和复发后结局。
Acta Oncol. 2021 Sep;60(9):1106-1113. doi: 10.1080/0284186X.2021.1943519. Epub 2021 Jun 29.
6
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.局限性结肠癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2020 Oct;31(10):1291-1305. doi: 10.1016/j.annonc.2020.06.022. Epub 2020 Jul 20.
7
Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline.结直肠癌的早期检测:美国临床肿瘤学会资源分层指南
J Glob Oncol. 2019 Feb;5:1-22. doi: 10.1200/JGO.18.00213.
8
Role of surveillance imaging and endoscopy in colorectal cancer follow-up: Quality over quantity?结直肠癌随访中监测影像学和内镜的作用:质量优于数量?
World J Gastroenterol. 2019 Jan 7;25(1):59-68. doi: 10.3748/wjg.v25.i1.59.
9
Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.治疗后监测检测强度与结直肠癌患者复发检测的关系。
JAMA. 2018 May 22;319(20):2104-2115. doi: 10.1001/jama.2018.5816.
10
Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.更频繁与不那么频繁的随访检测对 II 期或 III 期结直肠癌患者总死亡率和结直肠癌特异性死亡率的影响:COLOFOL 随机临床试验。
JAMA. 2018 May 22;319(20):2095-2103. doi: 10.1001/jama.2018.5623.